3 not yet recruiting. 2 Phase 4, 1 Not applicable.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 2 | Not yet recruiting 2 |
| Not applicable | 1 | Not yet recruiting 1 |
Follow Yunlong Wang: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Effect of Tirzepatide on Recurrence of Atrial Fibrillation After Catheter Ablation in Obese Patients Tirzepatide, Structured Lifestyle Intervention - Atrial Fibrillation, Obesity & Overweight | Phase 4 | Not yet recruiting | Yunlong Wang | 710 | 2026-09-01 | 2026-07-21 |
| Tirzepatide on Atrial Fibrillation Recurrence After Catheter Ablation in Patients With Obesity and HFpEF Tirzepatide, Structured Lifestyle Intervention - Atrial Fibrillation, Heart Failure With Preserved Ejection Fraction (HFpEF) | Phase 4 | Not yet recruiting | Yunlong Wang | 602 | 2026-08-01 | 2026-06-05 |
| The COMBINE-AF Trial Linear ablation of mitral isthmus and tricuspid isthmus, Ethanol, Radiofrequency Ablation Catheter - Atrial Fibrillation (AF), Atrial Fibrillation Catheter Ablation | Not applicable | Not yet recruiting | Yunlong Wang | 430 | 2026-07-27 | 2026-07-27 |
Atrial Fibrillation (3) · Obesity (2) · Overweight (1)
Tirzepatide (2) · Catheter Ablation (1) · Ethanol (1)
China (2)